|4.81||+0.03 / +0.63%|
As of 3:59pm ET
|4.81||0.00 / 0.00%|
The 3 analysts offering 12-month price forecasts for Endocyte Inc have a median target of 10.00, with a high estimate of 12.00 and a low estimate of 9.00. The median estimate represents a +107.90% increase from the last price of 4.81.
The current consensus among 4 polled investment analysts is to Buy stock in Endocyte Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.